$FIGS

FIGS Just Gained 49% in a Month: Take Profits, or Buy More?

FIGS stock rose 48.9% in October, outperforming the S&P 500. Q2 revenue grew 28.8% to $196.6M, prompting a full-year growth outlook raise to 20%. Shares trade at 55x forward earnings, with analysts expecting 6% EPS growth in 2027. The company's strong performance and momentum drove gains, but valuation is now premium.

Original reporting
Published Oct 27, 2026, 8:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FIGS Just Gained 49% in a Month: Take Profits, or Buy More? — source image
Decision brief

The 30-second read

$FIGSBullishLow
01

Why it matters

The earnings beat and raised outlook provide fresh positive catalyst, but high forward multiple may limit upside.

02

Market read

First earnings report of the quarter with new guidance; relevant for traders considering positions in FIGS or the health‑apparel niche.

03

What to watch

Tariff refund boost to margins may not be repeatable; international revenue growth sustainability uncertain.

Relevance 4/10Novelty 4/10Timing: post‑earnings reaction today

Background

FIGS is a healthcare apparel company that has been rallying on momentum and improving fundamentals.

Company-level read

Ticker impact

$FIGSBullishMedium confidence
Context

Q2 earnings showed revenue of $196.6M (+28.8% YoY) and EPS beat, prompting management to raise full-year revenue outlook to ~20%.

Expected impact

potential modest upside as investors digest the beat, but likely pressure from valuation concerns.

Evidence & confidence

Strong earnings and guidance lift sentiment, yet 55x forward earnings suggests some downside risk.

Market effects

Highlights growth potential in healthcare apparel, may boost peer sentiment.

U.S. small‑cap health‑tech segment sees renewed interest.

Limited to U.S. equity markets.

Counterpoint

Valuation is stretched; a pullback could occur despite earnings beat.

Key entities

  • Trina Spear

    CEO of FIGS who highlighted traction across the business.

Related articles

$FIGSHighAI 9/10

FIGS (FIGS) Q2 2026 Earnings Call Transcript

FIGS, Inc. (FIGS) reported Q2 2026 net revenues of $196.6 million, up 28.8%, driven by higher order volume and record average order values. Scrubwear revenue rose 26.5% to $161.2 million. Gross margin was 75.2% and net income $28.4 million. The company raised FY2026 net revenue guidance to about 20% growth and EBITDA margin to 14.8% to 15.0%.

$FIGSMedAI 8/10

FIGS Stock Soars After Earnings Beat And Upgraded Outlook

FIGS Inc. (NYSE: FIGS) shares rose about 28.7% in a week after a Q2 earnings beat and an upgraded FY26 outlook, according to the article. Q2 results included EPS $0.15 vs $0.07 and revenue up 29% to $196.6M, with gross margin 66.6% and adjusted EBITDA margin 18.6%. FY26 guidance was raised to about 20% revenue growth and 14.8% to 15% EBITDA margin.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$FIGSHighAI 9/10

FIGS Stock Jumped 27% on Its Q2 Beat. The Raised Guide Did the Real Work.

FIGS (FIGS) shares rose about 27% on Aug. 7 after Q2 results beat estimates and management raised full-year guidance. Q2 revenue was $196.6M (+29% YoY) and EPS was $0.15 vs $0.07 consensus. Gross margin hit 75.2% but included a one-time tariff refund; core margin improved. Full-year growth guidance lifted to ~20% from 14% to 16%, plus a $100M buyback authorization.